Lund
Sweden
13
2025-01-16
8
2026-04-14
These are the the leading inventors for applications assigned to Xintela AB:
Xintela AB based in Lund, SE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Marker for Neural Stem Cells
#2 | 2024-07-25 ✅ Patent 12,599,633 granted on 2026-04-14Mesenchymal Stem Cells for Use in the Treatment of Skin Defects
#3 | 2023-11-02 ✅ Patent 12,247,222 granted on 2025-03-11Quality assurance of chondrocytes
#4 | 2023-11-02Stem Cells for Treatment of Respiratory Disorders
#5 | 2023-04-27Prevention and treatment of bone and cartilage damage or disease
#6 | 2021-10-14Detection and Treatment of Malignant Tumours in the CNS
#7 | 2020-12-03 ✅ Patent 11,725,188 granted on 2023-08-15Quality assurance of chondrocytes
#8 | 2020-02-06 ✅ Patent 11,517,593 granted on 2022-12-06Prevention and treatment of bone and cartilage damage or disease
#9 | 2019-12-05Marker for Neural Stem Cells
#10 | 2019-10-03 ✅ Patent 10,781,424 granted on 2020-09-22Quality assurance of chondrocytes
#11 | 2018-08-23 ✅ Patent 10,994,022 granted on 2021-05-04Detection and treatment of malignant tumours in the CNS
#12 | 2016-11-03 ✅ Patent 10,087,253 granted on 2018-10-02Monoclonal antibody capable of binding integrin alpha 10 beta 1
#13 | 2014-04-10 ✅ Patent 9,365,649 granted on 2016-06-14Monoclonal antibody capable of binding integrin alpha 10 beta 1
Also check out Xintela AB's (Lund, Sweden) applicant profile with 8 patent applications submitted.
138556 ⎘